Emergent Biosolutions EBS Convertible Preferred Stock Authorized Shares
Convertible Preferred Stock Authorized Shares at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's convertible preferred stock authorized shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's convertible preferred stock authorized shares?
- Emergent Biosolutions (EBS) reported convertible preferred stock authorized shares of 15M in Q1 2026.
- How has Emergent Biosolutions's convertible preferred stock authorized shares changed year-over-year?
- Emergent Biosolutions's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 15M to 15M.
- What is the long-term trend for Emergent Biosolutions's convertible preferred stock authorized shares?
- Over 5 years (2020 to 2025), Emergent Biosolutions's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 15M to 15M.
- What does convertible preferred stock authorized shares mean?
- Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.